Injective: down on the short term, up in the long run

COINBASE:INJUSD   Injective Protocol
I wouldn't consider buying Injective at the moment. The price surged sharply from $6 to $40, and a pullback after such a steep increase is only logical. The presence of a yellow horizontal line above two peaks suggests an upcoming downtrend, which indeed occurred. While the fundamentals of Injective are sound, there's a possibility it could experience a further $10 drop in a corrective move. Following this consolidation, it might find its way back up, and in that upward trajectory, it's likely to surpass its all-time high (ATH) of $45. From there, it's expected to reach at least $66.9. However, predicting the new ATH depends on market conditions, and it's challenging to foresee when an upward trend will halt.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.